The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.
The DCP Community Oncology and Prevention Trials Research Group administers this program.
On This Page
- All Headings will automatically be pulled in to this list.
- Do not edit the content on this template.
About NCORP
The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.
Grantee Details
No matching Grants were found.
Clinical Trials
Title | Intervention | Sponsor | Status Sort descending |
---|---|---|---|
Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy | Best Practice, Quality-of-Life Assessment, Questionnaire Administration, Wound Dressing Material | Alliance for Clinical Trials in Oncology | Active, not recruiting |
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer | Duloxetine, Duloxetine Hydrochloride, Oxaliplatin, Placebo, Quality-of-Life Assessment, Questionnaire Administration | Alliance for Clinical Trials in Oncology | Active, not recruiting |
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer | Hypofractionated Radiation Therapy, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration, Radiation Therapy | Alliance for Clinical Trials in Oncology | Active, not recruiting |
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ | Cytology Specimen Collection Procedure, Endocrine Therapy, Laboratory Biomarker Analysis, Magnetic Resonance Imaging, Quality-of-Life Assessment, Radiation Therapy, Therapeutic Conventional Surgery, Therapeutic Surgical Procedure | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
Understanding and Predicting Breast Cancer Events After Treatment | Cardiac MRI | Wake Forest University Health Sciences | Active, not recruiting |
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis | Infliximab, Intravenous Immunoglobulin Therapy, Prednisone, Quality-of-Life Assessment, Questionnaire Administration | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer | Endocrine therapy interruption | ETOP IBCSG Partners Foundation | Active, not recruiting |
Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy | Cognitive Assessment, Computer-Assisted Cognitive Training, Psychosocial Assessment and Care, Quality-of-Life Assessment, Questionnaire Administration | Children's Oncology Group | Active, not recruiting |
NCI COVID-19 in Cancer Patients, NCCAPS Study | Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration | National Cancer Institute (NCI) | Active, not recruiting |
Reproductive Health Program in Patients With Cancer | Standard practice related to reproductive heath, Training modules, algorithm, referral development | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
Publications
News and Events
NCI-Funded Research at the 2024 San Antonio Breast Cancer Symposium December 10-13
Date Posted: November 25, 2024
NCORP-supported Research Shows Olanzapine May Reduce Chemotherapy-Induced Nausea
Date Posted: September 30, 2024
NCORP recognizes Judith Hopkins, Kristina Gardner, and Marge Good with 2024 awards
Date Posted: September 26, 2024
AACR Announces 2024 Distinguished Public Service Award Recipients
Date Posted: February 19, 2024
Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up
Date Posted: December 22, 2023